• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Retrospective investigation of "paint brush borders" sign in association with local recurrence of giant cell tumor of bone after intralesional curettage.

作者信息

He Yifeng, Wang Jun, Rui Weiwei, Lin Juiming, Yuan Fei, Du Lianjun, Zhang Ji, Ding Xiaoyi

机构信息

Department of Radiology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China, and Department of Radiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Shanghai Institute of Traumatology and Orthopaedics, Shanghai Key Laboratory for Prevention and Treatment of Bone and Joint Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

出版信息

J Bone Oncol. 2017 Nov 27;10:41-48. doi: 10.1016/j.jbo.2017.11.002. eCollection 2018 Mar.

DOI:10.1016/j.jbo.2017.11.002
PMID:29255669
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5725224/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0450/5725224/08f5cd028460/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0450/5725224/143d221cae55/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0450/5725224/bc634fa09ae1/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0450/5725224/44a5494e7a4a/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0450/5725224/e9dc5d5eca91/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0450/5725224/08f5cd028460/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0450/5725224/143d221cae55/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0450/5725224/bc634fa09ae1/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0450/5725224/44a5494e7a4a/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0450/5725224/e9dc5d5eca91/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0450/5725224/08f5cd028460/gr5.jpg

相似文献

1
Retrospective investigation of "paint brush borders" sign in association with local recurrence of giant cell tumor of bone after intralesional curettage.关于“刷状边缘”征与骨巨细胞瘤病灶内刮除术后局部复发相关性的回顾性研究。
J Bone Oncol. 2017 Nov 27;10:41-48. doi: 10.1016/j.jbo.2017.11.002. eCollection 2018 Mar.
2
Tumor immunohistochemistry and preoperative magnetic resonance imaging features predict local recurrence of giant cell tumor of bone following intralesional curettage.肿瘤免疫组织化学和术前磁共振成像特征可预测骨巨细胞瘤病灶内刮除术后的局部复发。
Oncol Lett. 2019 Feb;17(2):1425-1434. doi: 10.3892/ol.2018.9778. Epub 2018 Nov 30.
3
Magnetic resonance feature of "paintbrush borders" sign as a novel way to predict recurrence of giant cell tumor of bone after curettage: a pilot study.“画笔边缘”征的磁共振特征作为预测骨巨细胞瘤刮除术后复发的新方法：一项初步研究
J Int Med Res. 2018 Feb;46(2):710-722. doi: 10.1177/0300060517720345. Epub 2017 Sep 12.
4
Segmental excision versus intralesional curettage with adjuvant therapy for giant cell tumour of bone.骨巨细胞瘤的节段性切除与病灶内刮除加辅助治疗对比
J Orthop Surg (Hong Kong). 2016 Apr;24(1):88-91. doi: 10.1177/230949901602400120.
5
Zoledronic acid-loaded bone cement as a local adjuvant therapy for giant cell tumor of the sacrum after intralesional curettage.唑来膦酸负载骨水泥作为骶骨骨巨细胞瘤刮除术后的局部辅助治疗。
Eur Spine J. 2015 Oct;24(10):2182-8. doi: 10.1007/s00586-015-3978-y. Epub 2015 May 5.
6
Local recurrence of giant cell tumor of bone after intralesional treatment with and without adjuvant therapy.骨巨细胞瘤病灶内治疗后伴或不伴辅助治疗的局部复发情况。
J Bone Joint Surg Am. 2008 May;90(5):1060-7. doi: 10.2106/JBJS.D.02771.
7
MRI assessment of the bone adjacent to giant cell tumours and its association with local recurrence after intralesional curettage.巨细胞瘤邻近骨质的MRI评估及其与病灶内刮除术后局部复发的相关性
Clin Radiol. 2018 Nov;73(11):984.e19-984.e28. doi: 10.1016/j.crad.2018.06.021. Epub 2018 Sep 15.
8
Local recurrence after curettage treatment of giant cell tumors in peripheral bones: retrospective study by the GSF-GETO (French Sarcoma and Bone Tumor Study Groups).外周骨骨巨细胞瘤刮除治疗后局部复发：GSF-GETO（法国肉瘤和骨肿瘤研究组）的回顾性研究。
Orthop Traumatol Surg Res. 2013 Oct;99(6 Suppl):S313-8. doi: 10.1016/j.otsr.2013.07.006. Epub 2013 Aug 23.
9
Surgery methods and soft tissue extension are the potential risk factors of local recurrence in giant cell tumor of bone.手术方法和软组织扩展是骨巨细胞瘤局部复发的潜在危险因素。
World J Surg Oncol. 2016 Apr 19;14:114. doi: 10.1186/s12957-016-0871-z.
10
Higher local recurrence rates after intralesional surgery for giant cell tumor of the proximal femur compared to other sites.与其他部位相比，股骨近端骨巨细胞瘤行病灶内手术后局部复发率更高。
Eur J Orthop Surg Traumatol. 2017 Aug;27(6):813-819. doi: 10.1007/s00590-017-1983-z. Epub 2017 Jun 6.

引用本文的文献

1
Applications of artificial intelligence in orthopaedic surgery.人工智能在骨科手术中的应用。
Front Med Technol. 2022 Dec 15;4:995526. doi: 10.3389/fmedt.2022.995526. eCollection 2022.
2
State of the Art and New Concepts in Giant Cell Tumor of Bone: Imaging Features and Tumor Characteristics.骨巨细胞瘤的现状与新概念：影像学特征及肿瘤特性
Cancers (Basel). 2021 Dec 15;13(24):6298. doi: 10.3390/cancers13246298.
3
Prediction of the early recurrence in spinal giant cell tumor of bone using radiomics of preoperative CT: Long-term outcome of 62 consecutive patients.

本文引用的文献

1
Prognosis of local recurrence in giant cell tumour of bone: what can we do?骨巨细胞瘤局部复发的预后：我们能做些什么？
Radiol Med. 2017 Jul;122(7):505-519. doi: 10.1007/s11547-017-0746-6. Epub 2017 Mar 7.
2
Prognostic role of nuclear factor/IB and bone remodeling proteins in metastatic giant cell tumor of bone: A retrospective study.核因子/κB与骨重塑蛋白在骨转移性巨细胞瘤中的预后作用：一项回顾性研究。
J Orthop Res. 2015 Aug;33(8):1205-11. doi: 10.1002/jor.22873. Epub 2015 Apr 2.
3
Risk factors for recurrence of giant cell tumours of bone.
利用术前CT的影像组学预测脊柱骨巨细胞瘤的早期复发：62例连续患者的长期结果
J Bone Oncol. 2021 Mar 16;27:100354. doi: 10.1016/j.jbo.2021.100354. eCollection 2021 Apr.
4
Revisiting the WHO classification system of bone tumours: emphasis on advanced magnetic resonance imaging sequences. Part 2.重新审视世界卫生组织骨肿瘤分类系统：重点关注先进的磁共振成像序列。第2部分。
Pol J Radiol. 2020 Aug 10;85:e409-e419. doi: 10.5114/pjr.2020.98686. eCollection 2020.
5
Radiological Features of Giant Cell Tumours of Bone.骨巨细胞瘤的放射学特征
Cureus. 2020 Jun 24;12(6):e8793. doi: 10.7759/cureus.8793.
6
Clinical Significance of MRI and Pathological Features of Giant Cell Tumor of Bone Boundary.骨边界巨细胞瘤的 MRI 临床意义及病理特征。
Orthop Surg. 2019 Aug;11(4):628-634. doi: 10.1111/os.12510. Epub 2019 Aug 18.
7
Convolutional neural network to predict the local recurrence of giant cell tumor of bone after curettage based on pre-surgery magnetic resonance images.基于术前磁共振图像的卷积神经网络预测骨巨细胞瘤刮除术后局部复发。
Eur Radiol. 2019 Oct;29(10):5441-5451. doi: 10.1007/s00330-019-06082-2. Epub 2019 Mar 11.
骨巨细胞瘤复发的危险因素。
J Orthop Surg (Hong Kong). 2014 Apr;22(1):108-10. doi: 10.1177/230949901402200127.
4
The clinical approach toward giant cell tumor of bone.骨巨细胞瘤的临床治疗方法。
Oncologist. 2014 May;19(5):550-61. doi: 10.1634/theoncologist.2013-0432. Epub 2014 Apr 9.
5
MiR-126-5p regulates osteoclast differentiation and bone resorption in giant cell tumor through inhibition of MMP-13.miR-126-5p 通过抑制 MMP-13 调节破骨细胞分化和巨细胞瘤骨吸收。
Biochem Biophys Res Commun. 2014 Jan 17;443(3):944-9. doi: 10.1016/j.bbrc.2013.12.075. Epub 2013 Dec 19.
6
Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study.地舒单抗治疗成人和骨骼成熟青少年骨巨细胞瘤的安全性和有效性：一项开放标签、平行组、2 期研究的中期分析。
Lancet Oncol. 2013 Aug;14(9):901-8. doi: 10.1016/S1470-2045(13)70277-8. Epub 2013 Jul 16.
7
Immunoexpression of RANK, RANKL, OPG, VEGF, and vWF in radicular and dentigerous cysts.在根型和含牙型囊肿中 RANK、RANKL、OPG、VEGF 和 vWF 的免疫表达。
J Oral Pathol Med. 2013 Jul;42(6):468-73. doi: 10.1111/jop.12036. Epub 2012 Dec 27.
8
Giant cell tumor of bone: a basic science perspective.骨巨细胞瘤：基础科学视角。
Bone. 2013 Jan;52(1):238-46. doi: 10.1016/j.bone.2012.10.002. Epub 2012 Oct 9.
9
Matrix metalloproteinases: changing roles in tumor progression and metastasis.基质金属蛋白酶：在肿瘤进展和转移中的变化作用。
Am J Pathol. 2012 Dec;181(6):1895-9. doi: 10.1016/j.ajpath.2012.08.044. Epub 2012 Oct 12.
10
Giant cell tumor with pathologic fracture: should we curette or resect?病理性骨折的巨细胞瘤：我们应该刮除还是切除？
Clin Orthop Relat Res. 2013 Mar;471(3):820-9. doi: 10.1007/s11999-012-2546-6.